Group items tagged

Astronomers eagerly await the launch of the $8 billion James Webb Space Telescope. It will see back in time farther than any space telescope ever has before-back to the first light following the big bang. It will watch the first stars and galaxies form. And it will hunt for distant habitable planets by peering into their atmospheres. Expectations are high for the science that will come from the $8.7 billion James Webb Space Telescope-the successor to the Hubble Space Telescope. The telescope's four main science instruments are now all in one place, as are its 18 mirror sections. When assembled in space, they will create the largest orbiting mirror ever seen. For more related topic: http://koyalgroupinfomag.com/ https://twitter.com/koyalgroup http://koyalgroup1.blogspot.com/

We live in an age shaped by scientific research. Medical practice, for example, changes a bit each year because of new discoveries in the laboratory or in drug trials. We have come to expect progress in a variety of technical fields, and science often lives up to our hopes for it. But science can also falter. One of the challenges for non-scientists - whom I call "normal people" - must address is how to interpret new scientific studies. Which ones contain valuable information that should influence our activities or government policies? Which can be put on the back burner of our minds, awaiting further evidence? Scientists are human. Scientists are people. We do our best, but that doesn't make us perfect. Scientists have several reasons to try to promote the work that's been done, quite apart from whatever merit it may have. Scientists want to have successful careers and that means promoting results obtained in the lab or field. For some scientists, professional status really matters, and for most scientists today, further funding is an issue always kept in mind. Dr. E. Kirsten Peters, a native of the rural Northwest, was trained as a geologist at Princeton and Harvard. This column is a service of the College of Agricultural, Human, and Natural Resource Sciences at Washington State University. Read This Article

Hi. I am Art Caplan, from the NYU Langone Medical Center, Division of Medical Ethics. What is going on in the field of regenerative medicine with respect to stem cell research? We have recently had yet another in a long series of scandals involving claims about the ability to manipulate stem cells in ways that turned out to be utterly untrue and fraudulent. In this case, a scientist in Japan said that she was able to make adult stem cells revert to embryo-like stem cells with some pretty simple chemical exposures. It was announced in leading journals and covered extensively by the media. Then she had to admit that no one could duplicate what she had done and confessed that she had made it up. This is not the first time that this has happened in the stem cell field. Going back all the way to right after Dolly the sheep was cloned, people were trying to clone human embryos to see if they could get cloned human embryos from stem cells. A group in Korea announced that they had made the first cloned human embryos. Nobody could replicate what they did, and they ultimately had to retract their claims published in leading scientific journals that they had cloned human embryos. Stem cell research seems again and again to go off the rails when it comes to the ethics of research. What is going on and why is that so? I think there are a couple of reasons why this particular area has gotten itself in so much hot water. One is that there is a relative shortage of funding. Because of the controversial nature of cloning -- getting stem cells from human embryos -- some avenues of funding have dried up, and it puts pressure on people to come up with other ways to try to make human stem cells. With less funding, there is more pressure. Sometimes people cut corners. I think that can l